...
首页> 外文期刊>International Urology and Nephrology >Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma.
【24h】

Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma.

机译:增殖细胞核抗原(PCNA)的过表达和微血管密度可预测膀胱癌的生存。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: To study proliferating cell nuclear antigen (PCNA) over expression and angiogenesis with their relationship to tumor parameters in squamous cell carcinoma of the urinary bladder in patients who underwent radical cystectomy. Patients and methods: The mean age of the patients was 53.53 years (range; 29-70 years) and the males were 98 of 154. Sections from paraffin embedded tissues were retrieved and stained with antibodies against PCNA for proliferation and CD34 for angiogenesis using immunohistochemical technique. Fisher's exact test was used to evaluate the relationship between categorical variables and the Kaplan-Meier procedure was used to assess survival outcomes. The Cox regression model was used for multivariate analysis. Results: The median follow up period was 65 months. microvessel density (MVD), PCNA, tumor grade, P-stage, DNA ploidy, lymph node status had a significant impact on the 5-year survival of patients in univariate analysis. In Cox proportional hazard model, MVD, PCNA, DNAploidy and stage sustained their significant impact on survival of the patients. Conclusions: MVD, PCNA, DNA ploidy and stage are independent prognostic factors in patients with squamous cell carcinoma of the urinary bladder.
机译:目的:研究行根治性膀胱切除术的膀胱鳞状细胞癌中增殖细胞核抗原(PCNA)的过度表达和血管生成及其与肿瘤参数的关系。患者和方法:患者的平均年龄为53.53岁(范围; 29-70岁),男性为154人中的98岁。取自石蜡包埋组织的切片,并用免疫组织化学方法对PCNA抗体进行增殖染色,对CD34进行血管生成染色。技术。 Fisher精确检验用于评估分类变量之间的关系,而Kaplan-Meier程序用于评估生存结果。 Cox回归模型用于多变量分析。结果:中位随访期为65个月。在单变量分析中,微血管密度(MVD),PCNA,肿瘤等级,P期,DNA倍性,淋巴结状态对患者的5年生存率有重大影响。在Cox比例风险模型中,MVD,PCNA,DNA倍性和分期对患者的生存具有重大影响。结论:MVD,PCNA,DNA倍性和分期是膀胱鳞状细胞癌患者的独立预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号